Clinical Trial Update: Phase II Study With ITF2984 in Acromegalic Patients [Phase 2]

View source ↗

Summary

Phase II trial of ITF2984 in acromegaly has completed; no efficacy results are provided in the available summary.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly

Drugs mentioned

• ITF2984 (ITF2984)

Snippet

Sponsor: Italfarmaco | Conditions: Acromegaly | Phase 2 | Status: COMPLETED